Award comes as his Rochester startup sees demand spike for its patented tech.
The biotech company also added three new board members as two departed.
The buyer, Cardinal Health, will receive ownership of medical products used in “nearly every U.S. hospital.”
Mayo-backed viral oncology firm graduating from clinic’s biz incubator.
If the deal closes, it would be a roughly $1 billion step up from what the business was expected to sell for.
High-tech mouth guard detects possible concussions.
The two Minn. institutions combined for more than $500M in NIH funding last year.
Five life sciences research projects nearing market stage land MN-REACH funding.
The medtech company reported mid-single digit sales growth in all four of its business groups.